Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 683 | -2,715 | 83,053 | 21,309 | N/A |
| Depreciation Amortization | 7,193 | 4,297 | 18,678 | 18,283 | N/A |
| Accounts receivable | N/A | N/A | 332 | -1,172 | N/A |
| Other Working Capital | -4,855 | -1,309 | -14,147 | 11,282 | N/A |
| Other Operating Activity | 11,976 | 30,709 | 12,515 | -6,395 | 0 |
| Operating Cash Flow | $14,997 | $30,982 | $100,431 | $43,307 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,987 | -6,332 | -17,563 | -20,694 | N/A |
| Purchase Of Investment | -109,791 | -126,514 | -412,887 | -611,743 | N/A |
| Sale Of Investment | 91,958 | 217,191 | 415,345 | 567,421 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -17,500 | -35,000 | N/A |
| Other Investing Activity | -6,327 | -1,554 | -17,500 | -35,000 | 0 |
| Investing Cash Flow | $-26,147 | $82,791 | $-32,605 | $-100,016 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 275,000 | N/A |
| Debt Repayment | -15,602 | -74,783 | -49,732 | -262,146 | N/A |
| Common Stock Issued | 603 | 1,143 | 1,253 | 1,090 | N/A |
| Common Stock Repurchased | -2,015 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,107 | -475 | 0 | -7,726 | 0 |
| Financing Cash Flow | $-18,121 | $-74,115 | $-48,479 | $6,218 | $N/A |
| Beginning Cash Position | 79,711 | 40,053 | 20,706 | 71,197 | N/A |
| End Cash Position | 50,440 | 79,711 | 40,053 | 20,706 | N/A |
| Net Cash Flow | $-29,271 | $39,658 | $19,347 | $-50,491 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,997 | 30,982 | 100,431 | 43,307 | N/A |
| Capital Expenditure | -1,987 | -6,332 | -17,563 | -20,694 | N/A |
| Free Cash Flow | 13,010 | 24,650 | 82,868 | 22,613 | 0 |